Home News Discover the latest breakthroughs, stories, and updates from Oncode Institute’s mission to outsmart cancer. Search Category Category Blog Post External Events Funding Research news Our Team press news Exploring vulnerabilities in drug-tolerant colon cancer cells 7 Apr 2023 Oncode Clinical Proof of Concept funded International Leukemia Target Board (iLTB) is now ready for its next steps 31 Mar 2023 New study Sjoerd van der Burg Lab on underlying mechanisms in immunotherapy resistance 17 Mar 2023 Cyclomics starts new research collaboration with Oxford Nanopore Technologies 16 Mar 2023 Hugo Snippert wins 2023 Ammodo Science Award for fundamental research 7 Mar 2023 Oncode Investigators Tineke Lenstra and Jurgen Marteijn receive ENW-M collaborative grant 3 Mar 2023 DNA testing predicts ineffective chemotherapy treatment for colon cancer patients 2 Mar 2023 New EU-funded Project: Fragment-Screen 23 Feb 2023 Unexpected side effect sabotages immunotherapy 22 Feb 2023 Follow-up funding for Oncode Institute to keep cracking the code of cancer 9 Feb 2023 UNCAN.EU survey: identify the next challenges in cancer research! 6 Feb 2023 Hoopvolle trends in 2023 voor kankeronderzoek 3 Feb 2023 Eerste live bijeenkomst Oncode Patiënt Perspectief Programma brengt (ex-)patiënten en onderzoekers dichter bij elkaar 27 Jan 2023 Specialized immune cells carry potential for new cancer immunotherapies 11 Jan 2023 New technique to detect T cells that recognize a patient’s tumor 2 Jan 2023 Overlooked immune cell proves important for impact of immunotherapy 15 Dec 2022 Pagination Previous page ‹ … Page 9 Page 10 Page 11 Page 12 Current page 13 Page 14 Page 15 Page 16 Page 17 … Next page ›
Oncode Clinical Proof of Concept funded International Leukemia Target Board (iLTB) is now ready for its next steps 31 Mar 2023
Eerste live bijeenkomst Oncode Patiënt Perspectief Programma brengt (ex-)patiënten en onderzoekers dichter bij elkaar 27 Jan 2023
